Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pituitary Diseases × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 320 Precursor Cell Lymphoblastic Leukemia-Lymphoma 77 Lymphoma 57 Leukemia 55 Neoplasms, Plasma Cell 54 Recurrence 46 Neoplasms 32 Vomiting 31 Lymphoma, Non-Hodgkin 30 Lymphoma, Mantle-Cell 26 Immunoglobulin Light-chain Amyloidosis 25 Burkitt Lymphoma 22 Nausea 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Waldenstrom Macroglobulinemia 19 Lymphoma, Large B-Cell, Diffuse 18 Lymphoma, Follicular 18 Prostatic Neoplasms 16 Hodgkin Disease 16 Breast Neoplasms 14 Neoplasm Metastasis 11 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Myeloid, Acute 11 Amyloidosis 10 Ovarian Neoplasms 9 Lymphoma, Large-Cell, Immunoblastic 9 Carcinoma, Non-Small-Cell Lung 9 Lymphoma, T-Cell, Cutaneous 8 Colonic Neoplasms 8 Renal Insufficiency 7

Interventions

Mifepristone 3 Corlux 3 Thyrotropin-Releasing Hormone 1 Surgical Procedures, Operative 1 Radiotherapy 1 LY2940680 1 Hydrocortisone 1 Human Growth Hormone 1 Diazoxide 1 Dexamethasone 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed

43 enrolled 8 charts

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡